---
$id: https://graph.org.ai/products/commodity/51152027
$type: Product
source: UNSPSC
code: "51152027"
title: "Idrocilamide"
class: "51152000"
classTitle: "Neuromuscular blocking agents"
family: "51150000"
familyTitle: "Autonomic nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Idrocilamide

**UNSPSC Code**: 51152027
**Class**: [Neuromuscular blocking agents](Neuromuscular blocking agents.mdx)
**Family**: [Autonomic nervous system drugs](../Autonomic nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a muscle relaxant with the molecular formula C11H13NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6C816LUB1O, chemically known as 2-propenamide, n-(2-hydroxyethyl)-3-phenyl- but generally known as idrocilamide, which bears US NIH Compound Identifier 1550874. European Medicines Agency schedules Idrocilamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08121MIG. The term IDROCILAMIDE is an International Non-Proprietary Name. World Health Organization schedules idrocilamide in its Anatomical Therapeutic Chemical (ATC) Classification. IDROCILAMIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule idrocilamide under HS 29242995 and SITC 51479. As of Q4 2014, IDROCILAMIDE remains the US FDA Preferred Term for this commodity. Idrocilamide bears US NLM identifiers UMLS ID C0054086 and NCI Concept Code C74280. SMILES: C1=CC=C(C=C1)/C=C/C(=O)NCCO.

